Article
Metabolic consequences of recombinant human growth hormone therapy in patients with Turner syndrome
1 Jan 2023
Abstract excerpt
INTRODUCTION: Turner syndrome (TS) predisposes to metabolic complications. Currently, TS patients are treated with recombinant human growth hormone (rGH) as standard therapy. The long-term effect of this therapy on carbohydrate metabolism remains unclear. Aim of the study: To assess possible metabolic alterations following rGH therapy. MATERIAL AND METHODS: Material and methods: We enrolled 53 TS participants,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
